European Union

Medical Ice Slurry Production and Delivery Systems and Methods

The European Patent Office granted Patent EP3419572A1 to The General Hospital Corporation for ice slurry medical production and delivery systems. The patent covers methods and apparatus for producing and delivering ice slurry for medical applications, classified under A61M (medical delivery devices) and A61F (medical cooling). The designated states include all major European jurisdictions (DE, FR, GB, IT, ES, NL, BE, CH, etc.).

Staymed AB A61M Medical Device Patent, Published 1st Apr

The EPO published patent application EP3866877A2 by Staymed AB on April 1, 2026. The application covers A61M medical device technology for blood oxygenation (IPC A61M 1/16), with Per-Olov Carlsson listed as inventor. All European Patent Convention states are designated.

EP3656424A1 Subcutaneous Infusion Device for Medicinal Substance Injection, Takeda

The European Patent Office granted Patent EP3656424A1 to Takeda Pharmaceutical Company Limited on April 1, 2026, covering a subcutaneous infusion device for injecting medicinal substances. The patent names six inventors and includes IPC classifications for needle systems (A61M 5/32, A61M 5/158) and infusion catheters (A61M 25/06). The patent is designated for all EU member states plus several additional European countries.

Reduced-Pressure Treatment System Having Blockage Clearing and Dual-Zone Pressure Protection Capabilities

The European Patent Office has published patent EP3610898A1, granted to Solventum Intellectual Properties Company, covering a reduced-pressure treatment system with blockage clearing and dual-zone pressure protection capabilities. The patent, with inventors including Jonathan Paul Jaeb and Shannon C. Ingram, was published April 1, 2026. The designated states include EU member states AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, PL, PT, RO, SE, SI, SK, TR and others.

Self-Actuating Articles EP3624880A1 - MIT and Brigham and Women's Hospital

The European Patent Office published patent application EP3624880A1 titled 'Self-Actuating Articles' on April 1, 2026. The patent was filed by Massachusetts Institute of Technology and The Brigham and Women's Hospital, Inc., with inventors including Carlo Giovanni Traverso and Robert S. Langer. The invention covers medical devices in IPC classifications A61M (medical preparations, injectors) and A61B (diagnostic instruments), with designated states covering all European Patent Convention member countries.

Drexel EPO Patent - Cytokine Adsorption From Blood Using Graphitic Materials

The European Patent Office granted Patent EP3463509A1 to Drexel University covering open surface graphitic materials for adsorption of cytokines from blood. The patent, filed by inventors Gogotsi, Mochin, and Pescatore, is classified under A61M (medical devices) and B01J (adsorbents) and designates all EU member states as covered jurisdictions.

Nasal Dilator Device Patent EP3157476A1, ASAP Breatheassist

EPO published patent EP3157476A1 for nasal dilator devices on April 1, 2026, granting exclusive rights to ASAP Breatheassist Pty Ltd. The invention covers devices for nasal airway dilation, classified under IPC A61M, with inventors Pepper et al.

European Patent EP2983768, Sanofi Drug Delivery Device

European Patent EP2983768, Sanofi Drug Delivery Device

Methods and Systems for Creating and Scaling Informal Care Networks

The European Patent Office published Patent EP4639566A1, filed by Koninklijke Philips N.V., titled 'Methods and Systems for Creating and Scaling Informal Care Networks.' The patent covers systems and methods for establishing and expanding informal care networks, classified under G16H 10/60, G16H 40/20, G16H 40/67, and G16H 80/00 (Health Informatics).

Intelligent Drop-Out Prediction in Remote Patient Monitoring

EPO published patent application EP4639580A1 by Koninklijke Philips N.V. titled 'Intelligent Drop-Out Prediction in Remote Patient Monitoring.' The invention covers systems and methods using artificial intelligence to predict when patients will disengage from remote monitoring programs. The patent is classified under G16H (Health Informatics) and designates all relevant European member states.